Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting self and neo-epitopes with a modular self-adjuvanting cancer vaccine.
Belnoue E, Mayol JF, Carboni S, Di Berardino Besson W, Dupuychaffray E, Nelde A, Stevanovic S, Santiago-Raber ML, Walker PR, Derouazi M. Belnoue E, et al. Among authors: derouazi m. JCI Insight. 2019 Apr 23;5(11):e127305. doi: 10.1172/jci.insight.127305. JCI Insight. 2019. PMID: 31013258 Free PMC article.
Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect.
Hofer T, Rossi M, Carboni S, Di Berardino Besson W, von Laer D, Wollmann G, Derouazi M, Santiago-Raber ML. Hofer T, et al. Among authors: derouazi m. Cancers (Basel). 2021 Dec 3;13(23):6107. doi: 10.3390/cancers13236107. Cancers (Basel). 2021. PMID: 34885215 Free PMC article.
Cell-penetrating peptides-the Swiss Army knife of cancer vaccines.
Walker PR, Belnoue E, Dietrich PY, Derouazi M. Walker PR, et al. Among authors: derouazi m. Oncoimmunology. 2015 Dec 10;5(3):e1095435. doi: 10.1080/2162402X.2015.1095435. eCollection 2016 Mar. Oncoimmunology. 2015. PMID: 27141358 Free PMC article.
Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants.
Belnoue E, Di Berardino-Besson W, Gaertner H, Carboni S, Dunand-Sauthier I, Cerini F, Suso-Inderberg EM, Wälchli S, König S, Salazar AM, Hartley O, Dietrich PY, Walker PR, Derouazi M. Belnoue E, et al. Among authors: derouazi m. Mol Ther. 2016 Sep;24(9):1675-85. doi: 10.1038/mt.2016.134. Epub 2016 Jul 5. Mol Ther. 2016. PMID: 27377043 Free PMC article.
37 results